Inhibitor of CD59 Activity as an Adjunct to Antibody-Based Cancer Therapy
Summary A bacterial peptide fragment has been shown to facilitate antibody-mediated and complement-dependant cancer cytolysis.
Applications Contact Maryanne Fenerjian, PhD Office of Technology Development Tel: 617-432-3845 Email:
[email protected] For Further Information Please Contact the Director of Business Development Alex Szidon Email:
[email protected] Telephone: (617) 495-3067
Inventor(s):
Qin, Xuebin
Type of Offer:
Licensing
« More Medical Patents